Professional Documents
Culture Documents
Commentary
Key words: clinical decision making; diagnostic research; epidemiology; periodontal diseases; periodontitis pez, Department of Rodrigo Lo Periodontology, School of Dentistry, Faculty of Health Sciences, Aarhus University, Vennelyst Boulevard 9, DK-8000 Aarhus C, Denmark Tel.: +45 8942 4141 Fax: +45 8613 6550 e-mail: rlopez@odont.au.dk Submitted 9 June 2011; accepted 18 January 2012
The past 25 years have witnessed more than 10 different periodontal disease classication systems (110). However, these systems have consistently been introduced in the absence of clear evidence for their advantages over the one(s) used hitherto. The lack of agreement on the operational denition of periodontitis and the categorization of subjects into disease groups constitute a major problem for researchers and policy makers attempting to summarize the scientic evidence on periodontitis. In view of the countless proposals for a periodontal classication system (47, 9, 1129) made since Fauchard and Hunter initiated the classication endeavor, we nd it prudent to examine the driving forces for these many classication system proposals.
chronic diarrhea), patho-anatomical characteristics (e.g., gastric ulcer), physiological characteristics (e. g., arterial hypertension), metabolic characteristics (e.g., hypercholesterolemia), and etiology (e.g., asbestosis), and nally, some diseases are dened as syndromes (e.g., Basedows disease) (31). In periodontology, the dominant viewpoint has always been that periodontal disease classications should be based on etiology. Only recently, Armitage (32) stated that One of the main problems with any attempt at subclassifying this [CP] or other forms of periodontitis, is that these infections are polymicrobial and polygenic. In addition, the clinical expression of these diseases is altered by important environmental and host-modifying conditions (e.g. oral hygiene, smoking, emotional stress, diabetes). It is conceivable that with much more information and the application of sophisticated multivariate analyses, it may eventually be possible to subclassify the multiple forms of Chronic Periodontitis into discrete microorganism/host genetic polymorphism groups.. Obviously, the practical use of such a complicated classication system would be
385
extremely restricted. Periodontal researchers would face problems when attempting to gather reasonably sized homogeneous study groups, and periodontal clinicians would be likely to abandon such systems right away, deeming them useless for clinical purposes. It is therefore necessary to rethink the conceptual basis for periodontal disease classication systems.
leading. The problem is that disease is continuously confused with etiopathogenesis (38). At the end of the day, the purpose of all our activities, whether in research, public health, or clinical practice, is to be able to control disease.
386
continuum of disease severity such that the absence or low severity of periodontitis merges imperceptibly into high severity and extent (41 44). The most conspicuous determinants of the population distribution of signs of periodontitis are age and socioeconomic position. While smoking is a modiable factor that confers a considerable risk, the epidemiological features indicate that on a population basis, it might be more fruitful to understand the signs of periodontitis as resulting from exposure to many smaller risks. Although severe periodontitis has been observed to occur ` vre with rare diseases such as the PapillonLefe syndrome (45), it is clear that neither smoking nor rare syndromes can account for the major burden of periodontitis. Widespread exposure to smaller risks may actually produce many more cases than the conned exposure to a few large risks (40). When disease results from the exposure to many smaller risks, the population strategy for prevention and control, in the form of campaigns or structural prevention, stands a better chance of being fruitful in combating disease occurrence. As dentists, we should acknowledge that some of the interventions that might be relevant for the prevention and control of periodontitis at the population level do not fall within the territories of traditional dentistry. As an example, while many clinicians might engage in chair-side smoking cessation counseling (46), many more would probably see themselves unt for carrying out such activities, over and beyond of advising their patients to quit smoking (47). Although this does not preclude the dental team from engaging in campaigns or advocating structural prevention, they should bear in mind that quarterly chair-side antismoking sessions might have little impact.
paradigm has therefore led to the use of postgenomic molecular technologies (50) to resolve these complex diseases. The idea is that by reducing the problems of disease to problems of molecular science (48), the relevant molecules may be identied and interventions may be devised that stop the effects of these molecules in disease pathogenesis (51). While many continue to emphasize the promising prospects of this approach (51), increasing concern has been voiced over the fading returns in terms of novel disease interventions arising from the huge investments made in bench-to-bedside research (52, 53). While this state of affairs has commonly been attributed to underfunding of clinical research (54), the lack of academic prestige in clinical medicine (55), or the rush to use the new technologies (55, 56), some have also questioned the underpinning reductionist research paradigm (55, 57, 58). In 2004, the journal Perspectives in Biology and Medicine devoted an entire issue to this problem (59) and identied the conventional linear bench-to-bedside model of scientic progress as a key obstacle for therapeutic innovation (59).
387
to infection (61, 67), and mainstream periodontal research is increasingly characterized as a reductionist enterprise attempting to understand the whole by identifying all the constituent components and elucidating their precise role (55, 68). Wondering why this is so, we proposed as responsible a number of factors: (i) the replacement of the single-agent germ theory disease models with host, agent, and environment models; (ii) the political developments favoring individualism over the shared; (iii) the privilege given to the bench sciences at the expense of clinical and population-based studies in the slipstream of the human genome project; and (iv) the unjustied, yet widespread, belief that laboratory methods are less prone to errors and therefore produce results of higher validity and reliability than may be obtained using clinical and epidemiological methods (55). It is thus a common observation across different elds that bench science, a.k.a. molecular medicine, is more prestigious and academically rewarding than are the poor intellectual cousin sciences of clinical medicine and epidemiology (69). A further sign of the belief in the superiority of the bench research is the overwhelming condence that once the pathobiologic truth has been uncovered, the move from bench to clinical application will be straightforward. In the words of Kornman (62): Although even partial information should improve the ability to identify an individuals susceptibility to disease and a likely response to treatment, the complete expression of these networks should be a valuable tool for determining new preventive and therapeutic approaches (62). However, the ability to take a disease to pieces in molecular terms is not the same as being able to plan interventions with the necessary precision (50). Paraphrasing Rees (50), it seems worth bearing in mind that clinical periodontology may have little regard for a complete description of how a myriad of pathways result in any clinical state. Rather, its goal remains pragmatic; it denes cause by how successful intervention might be obtained, how one, of many, rate-limiting pathways may be circumvented. It is far from self-evident that the reductionist approach taken by current mainstream periodontal research will ever provide answers that are useful to clinicians dealing with patients, let alone for public dental health purposes. In this context, it may be worthwhile to draw on the priorities for genomics research in other complex diseases (49). According to this, genomics research should have high priority if (i)
there is a priori evidence for a genetic etiology of the disease (e.g., disease clustering within families), (ii) the ability to modify exposure or risk factors is limited, and (iii) the disease has a high public health impact. One may question whether any form of periodontal disease exists, which fullls these criteria. Ultimately, the verdict on the outcomes of different research approaches will be based on their health problem-solving capacity, and while the -omics technologies might eventually bring us closer to improved treatment modalities for individual patients, they stand little chance of being valuable in bringing about health for populations.
388
relationship, and it is only in response to stress and ecological pressure that the indigenous microora may change as the result of an ecological catastrophe (82). According to this ecological plaque hypothesis, host factors are as important for the development of periodontitis as are microorganisms, because host factors are mediated by inammation that affect the relative competitiveness of the bacteria, thereby favoring bacteria thriving under anaerobic and alkaline conditions (82). These include some of the main putative periodontal pathogens, although not uniquely so. In its most extreme, the insistence that infection plays the key role, while host or other factors are secondary modulating factors for the initiation and sustainment of destructive periodontal diseases, therefore implies that the preventive and treatment goals should aim at sterile mouths at all times. However, it would seem a much more feasible way forward to take on the complex disease view, thereby realizing that complex disorders may have not a single cause but a causal chain, or multiple such causal chains. These chains may involve genetics, environmental, social and biological risk factors. The effect of no one of these risk factors can be fully understood except in the context of all the other (83). It follows that one of the important consequences of the complex disease view is that no special key factor status can be given to any particular risk factor, because no risk factor works in isolation. While the wish may be understandable to maintain the infectious causal paradigm as a tribute to its founding fathers, it has been recognized by others that periodontitis does not exactly t the mould of a classical infectious disease there are multiple organisms associated with periodontitis that are present in the periodontal spaces even in undiseased mouths (79). The periodontal research community should therefore remain cautious that the infectious causal paradigm does not come to stand in the way of scientic progress. It is certainly a fact that exogenous exposures have attracted comparatively little research interest among major sections of the periodontal research community (84). What is called for is a recognition of the heterogeneity of the dening features of diseases, which avoids commitment to any universal theory of disease causation while still retaining what is useful in any theory that has been advanced, without implying its universality (85). Thus, periodontal cases may be identied where it is appropriate to adopt a specied microbial cause as a key element, but this should not be taken to
indicate that we are committed to a universal microbial theory of destructive periodontal disease (85).
389
Semmelweis, and Snow in the right direction in terms of their causal pathways and hence the control of these public health problems. Clearly, the conditions they studied comprised rather acute contagious diseases, and this undoubtedly made their study much easier than would have been the case had they been more chronic in nature. Even so, the value remains unquestionable also for chronic diseases of careful mapping of the disease occurrences to obtain better clues regarding the factors relevant to their resolution. The task is formidable, not because of the disease problems per se, but because such mapping necessitates data collection across time, space, and level (89), and the healthcare systems are not necessarily organized in a way that allows this approach to be taken for chronic diseases. The much-needed studies based on the ecosocial theory of disease distribution (89) are difcult to set up under the auspices of a dominant disease paradigm that understands causal mechanisms as biological phenomena only. Along this line of thinking, one may indeed speculate whether the predenition of periodontitis as a class of infectious chronic diseases is more a hindrance than a help for their improved prevention and clinical management. As previously alluded to, the infection/host-response periodontal disease paradigm has proven unhelpful from a disease classication point of view (38). More importantly, it seems to be precisely the infection/host-response periodontal disease paradigm that prevents us from looking upstream and paying more attention, as did Snow, Semmelweis, and Schleisner, to the mapping of the destructive periodontal disease occurrences with a view to identify environmental or contextual patterns of distribution that might provide us with clues to their important determinants. It would seem that the infection/hostresponse periodontal disease paradigm instead forces us to conceptualize overtly environmental exposures, such as smoking, and sociocultural constructs, such as race (55), as merely modifying oil to the pathogenic wheels of infection of the human body engine room. This view has rather dire implications in terms of leading to victim-blaming (90), just as the prioritization of only those factors that are amenable to control by the health professionals maintains the disease-controlling power within the realms of these professionals (89). The health of individuals and populations is just as important a part of the social justication for dental research as is the improvement of the clinical care for the individual patient (59). However, the health of
individuals and populations does not necessarily follow from the prioritization of improved care for the sick (40, 81). It is therefore clear that amendments are necessary to the infection/host-response periodontal disease paradigm such that a causal concept is allowed that embraces the biological processes as no more than the biological incorporation into the body of the material and social world in which we live, from in utero to death (89). In other words, it is insufcient to study periodontitis as a decontextualized biological process occurring within sick peoples bodies, because these biological processes cannot be understood without knowledge of history and individual and societal ways of living (48, 91, 92).
390
conceptual model of disease causation based on the ecosocial premise of embodiment. The key clues to the population patterns of disease distribution are found in the social, material, and ecological contexts in which we are born, develop, interact, and endeavor to live (99), and not so much in decontextualized lifestyles, behaviors, or exposures that interact with equally decontextualized genes. Lifestyles, behaviors, and exposures do not strike at random but are socially, culturally, materially, and ecologically patterned, and failure to incorporate this knowledge into the conceptual models of causal pathways will prompt us to draw the wrong conclusions and lead us to intervene by blaming everything on the victims (91).
value-laden and politicizing enterprise (100). However, the long-standing discussion over the impact of the causal conceptualization of considerable race-related health disparities (101) which is also manifest in dental health (55) only serves to show that the victim-blaming disembodied research approach is just as political as the more public health-oriented inequality-focused research (102). The unfortunate advantage of the victim-blaming research approach to individual risk factor identication focused on the interplay of individual lifestyles, behaviors, exposures, and genes is that it is much easier to conceal its political aspects from the public, thereby reducing its accountability and transparency. As stated by Rose, it is not possible to combat the iceberg of disease by continuing to cut off its tip (81). The iceberg problem must be tackled at the roots of the problem: the base and the contextual circumstances leading to its formation. This calls for application of the ecosocial theory for disease development and distribution in an attempt to integrate social and biological reasoning and a dynamic, historical, and ecological perspective to develop insights into the determinants of population distribution of disease (89, 99).
Concluding remarks
The core of the above argumentation is that there is an urgent need to abandon the prevailing idea that the periodontal disease classication should be based on etiology. We have argued that the signs and symptoms of periodontitis are widespread and universal and that their distributional characteristics point to a complex disease etiology involving many smaller risks in a myriad of combinations. It is therefore not feasible to continue the essentialistic hankering after periodontal disease classications based in etiopathogenetic considerations. Rather, a nominalistic approach should be adopted. In this approach, a disease name is no more than a label issued to a group of individuals that share certain observable dening characteristics. The name chosen to label the group (e.g., periodontitis) is just a brief statement of the common abnormality by which the particular group of patients with periodontitis can be identied. Importantly, the disease periodontitis is not restricted to encompass only those signs and symptoms that are made explicit by the label (the disease name), but encompasses the whole range
391
of signs and symptoms that may be observed in periodontitis-affected subjects. The number of disease entities necessary and sufcient for a useful periodontal classication should be determined by documented differences in the management of each entity (38, 103). A classication system involving many different disease entities is not relevant as long as the parameters of their management, that is, their treatment and prognosis, remain the same (38). The diagnostic distinction between two phenotypes makes little sense until it has been demonstrated, beyond reasonable doubt, that these two phenotypes are most successfully treated using different treatment modalities or have different prognoses after the same therapy. It follows that labels (and hence the classication) should be based on this-disease-needs-this-kindmanagement-and-control considerations, as has also been advocated for dental caries (104). Interestingly, some of the previous periodontal classication systems have had nominalistic features. For example, the distinction between prepubertal, juvenile, and adult periodontitis is nominalistic in the sense that age is an observable characteristic. Moreover, the distinction between prepubertal, juvenile, and adult periodontitis was also underpinned by notions of different treatments for these entities. Generalized prepubertal periodontitis was considered largely intractable necessitating the extraction of all erupted teeth followed by an edentulous period to prevent infection of nonerupted teeth (105). Repeated occlusal grinding was considered an element in the treatment of juvenile periodontitis (106), whereas adult periodontitis could be treated by conventional local periodontal therapy. However, the evidence for the different treatment modalities was anecdotal, and the treatment approaches for the different entities have since undergone many changes. In our view, the only new information that warrants a change of the disease classication system is new knowledge regarding the prognosis and the better treatment of identiable patient groups. All other knowledge should be kept out of the classication until new research has unequivocally demonstrated the utility of different treatment modalities or existence of different prognoses for new categories. This viewpoint is consistent with a nominalistic disease concept, but at variance with the essentialistic concept, which unfortunately continues to underpin most activities in the periodontal eld (38, 103, 107).
Periodontal destruction is a condition that comes in all sizes. Clinical attachment level loss forms a continuum in the population ranging from the barely perceptible destruction in a single site of which we need not take any notice to generalized and severe destruction affecting all remaining teeth in the dentition. Age confounds the picture, and what is severe and highly unusual among younger subjects may be mild and common among a senior. These characteristics force us to somehow incorporate age and to acknowledge the continuum of extent and severity of lesions in the classication of periodontitis. This was indeed achieved in the only truly nominalistic periodontal disease classication system so far proposed (8). While this classication system fullls many of the desirable properties of an ideal classication system, it is not supported by evidence for the need from a therapeutic point of view to distinguish the many categories involved. As it is clearly desirable that a classication system rests on evidence rather than personal idiosyncrasies, we encourage research linking clinical phenotypes to the response to specic therapeutic approaches.
Acknowledgements
This study was partially supported by a grant from the Danish Medical Research Council (Copenhagen, Denmark). The authors declare that there are no conicts of interest in this study.
References
1. Page RC, Schroeder HE. Periodontitis in man and other animals. A comparative review. Basel: Karger, 1982 2. Ferris RT, Listgarten MA, Caton JG, Armitage GC, Burmeister JA, Genco RJ et al. Consensus report. Discussion section. Proceedings of the world workshop in clinical periodontics. Princeton: American Academy of Periodontology; 1989; 2332. 3. Johnson NW, Grifths GS, Wilton JMA, Maiden MFJ, Curtis MA, Gillet IR et al. Detection of highrisk groups and individuals for periodontal diseases. J Clin Periodontol 1988;15:27682. 4. Suzuki JB. Diagnosis and classication of the periodontal diseases. Dent Clin North Am 1988;32:195 216. 5. Ranney RR. Classication of periodontal diseases. Periodontol 2000 1993;2:1325. 6. Attstro m R, Van der Velden U. Consensus report session I. In: Lang NP, Karring T, editors. Proceedings of the 1st European Workshop on Periodontology. London: Quintessence Publishing Co; 1994; 1206.
392
The rationale behind periodontal classications 7. Armitage GC. Development of a classication system for periodontal diseases and conditions. Ann Periodontol 1999;4:16. 8. Van der Velden U. Diagnosis of periodontitis. J Clin Periodontol 2000;27:9601. 9. Topic B. Classication of periodontal diseases. Int Dent J 1990;40:1715. 10. Van der Velden U. Purpose and problems of periodontal disease classication. Periodontol 2000 2005;39:1321. 11. Jaccard R. Terminologie des pyorrhees. Schweiz Monatsschr Zahnmed 1930;40:66172. 12. Thoma KH, Goldman HM. Classication and histopathology of parodontal disease. J Am Dent Assoc 1937;24:191528. 13. Miller SC, Pelzer RH. An original classication of alveolar types in periodontal diseases and its prognostic value: corroboration by plasma phosphatase determinations. J Am Dent Assoc 1939;26:56574. 14. Orban B. Classication and nomenclature of periodontal diseases. J Periodontol 1942;13:8891. 15. Lyons H. Report of nomenclature committee. J Am Dent Assoc 1943;30:11124. 16. Hine MK, Hine CL. Classication and etiology of periodontal disturbances. J Am Dent Assoc 1944;31:1297307. 17. Lyons H. Studies in dental nomenclature: a series. IV. A classication of periodontal diseases. J Periodontol 1946;17:247. 18. Hulin C. De la nomenclature odonto-stomatologique. Paradentologie 1949;3:82110. 19. Orban B. Classication of periodontal diseases. Paradentologie 1949;3:15968. 20. Lyons H, Kerr DM, Hine MK. Report from the 1949 Nomenclature Committee of the American Academy of Periodontology. J Periodontol 1950;21:403. 21. Schour I. Current problems in terminology and classication of gingival and periodontal disease. J Periodontol 1951;22:103. 22. Kerr DA. Classication and terminology for 1951 periodontal workshop. J Am Dent Assoc 1952;44:6214. 23. Bernier JL. Report of the committee on classication and nomenclature. J Periodontol 1957;28:568. 24. Carranza FA, Carranza FA Jr. A suggested classication of common periodontal disease. J Periodontol 1959;30:1407. 25. Lyons H, Bernier J, Goldman HM. Nomenclature and classication committee. J Periodontol 1959;30:747. 26. American Academy of Periodontology. Committee report and discussion. The etiology of periodontal disease. World workshop in periodontics. Chicago, IL: American Academy of Periodontology, 1966: 16777. 27. Ranney RR. Position paper and review of the literaturePathogenesis of periodontal disease. In: Klavan B, Genco R, Lo e H, Page R, Stern I, Thorpe J et al., editors. International conference on research in the biology of periodontal disease. Chicago, Illinois: The College of Dentistry, University of Illinois: 1977; 223307. 28. American Academy of Periodontology. Proceedings of the World Workshop in Clinical Periodontics. Consensus report, discussion section I. Periodontal diagnosis and diagnostic aids. Princeton, NJ: American Academy of Periodontology; 1989: 2332. Page RC, Eke PI. Case denitions for use in population-based surveillance of periodontitis. J Periodontol 2007;78:138799. World Health Organization. International classication of diseases (ICD); 2009; Available at: http:// www.who.int/classications/icd/en/ [cited 1 October 2009]. Wulff HR, Gtzsche PC. The disease classication. Rational diagnosis and treatment. Evidence-based clinical decision making, 3rd edn. Oxford: Blackwell Science; 2000; 3962. Armitage GC. Classifying periodontal diseases a long-standing dilemma. Periodontol 2000 2002;30:9 23. Murphy EA. Classication and diagnosis. The logic of medicine, 2nd edn. Baltimore: Johns Hopkins University Press; 1997; 11936. Wulff HR, Gtzsche PC. Rational diagnosis and treatment: evidence-based clinical decision-making, 3rd edn. Oxford: Blackwell Science, 2000: 1221. Offenbacher S, Barros SP, Singer RE, Moss K, Williams RC, Beck JD. Periodontal disease at the biolm-gingival interface. J Periodontol 2007;78:1911 25. Papapanou PN, Abron A, Verbitsky M, Picolos D, Yang J, Qin J et al. Gene expression signatures in chronic and aggressive periodontitis: a pilot study. Eur J Oral Sci 2004;112:21623. Murphy EA. Introduction. The logic of medicine, 2nd edn. Baltimore: Johns Hopkins University Press; 1997; 113. Baelum V, Lopez R. Dening and classifying periodontitis: need for a paradigm shift? Eur J Oral Sci 2003;111:26. Lopez R. Conceptual and methodological issues in the study of destructive periodontal diseases among the young. Aarhus, Denmark: Faculty of Health Sciences, Aarhus University; 2010. Rose G. The strategy of preventive medicine, 1st edn. Oxford: Oxford University Press, 1992: 1138. Baelum V, Fejerskov O, Manji F. Periodontal diseases in adult Kenyans. J Clin Periodontol 1988;15:44552. Baelum V, Manji F, Fejerskov O. The distribution of periodontal destruction in the population of nonindustrialized countries: evidence for the existence of high risk groups and individuals. In: Johnson NW, editor.Risk markers for oral diseases. Periodontal diseases. Markers of disease susceptibility and activity. Cambridge: Cambridge University Press; 1991; 2775. ndez O, Jara G, Baelum V. EpidemiLopez R, Ferna ology of clinical attachment loss in adolescents. J Periodontol 2001;72:166674. Dye BA, Tan S, Smith V, Lewis BG, Barker LK, Thornton-Evans G et al. Trends in oral health status: United States, 19881994 and 19992004. Vital Health Stat 2007;11:192. Toomes C, James J, Wood AJ, Wu CL, McCormick D, Lench N et al. Loss-of-function mutation in the cathepsin C gene result in periodontal disease and palmoplantar keratosis. Nat Genet 1999;23:4214.
29. 30.
31.
35.
36.
43. 44.
45.
393
pez & Baelum Lo 46. Little SJ, Hollis JF, Fellows JL, Snyder JJ, Dickerson JF. Implementing a tobacco assisted referral program in dental practices. J Public Health Dent 2009;69:14955. E, Campbell P, Tnnesen G, Gustavsson G, 47. Monso Morera J. Sociodemographic predictors of success in smoking intervention. Tob Control 2001;10:165 9. 48. Diez-Roux AV. On genes, individuals, and epidemiology. Am J Epidemiol 1998;148:102732. 49. Merikangas KR, Risch N. Genomic priorities and public health. Science 2003;302:599601. 50. Rees J. Complex disease and the new clinical sciences. Science 2002;296:698701. 51. Dill KA. Strengthening biomedicines roots. Nature 1999;400:30910. 52. Hunter P. More is less. New developments in funding the life sciences to make research more effective. EMBO Rep 2007;8:6268. 53. Charlton BG, Andras P. Medical research funding may have over-expanded and be due for collapse. Q J Med 2005;98:535. 54. Rosenberg RN. Translating biomedical research to the bedside. A national crisis and a call to action. J Am Med Assoc 2003;289:13056. 55. Baelum V, Lopez R. Periodontal epidemiology: towards social science or molecular biology? Community Dent Oral Epidemiol 2004;32:23949. 56. Holtzman NA, Marteau TM. Will genetics revolutionize medicine? N Engl J Med 2000;343:1414. 57. Rees J. The fundamentals of clinical discovery. Perspect Biol Med 2004;47:597607. 58. Schechter AN. Medicine and biology are more than biomedicine. Nature 1999;401:424. 59. Schechter AN, Perlman RL, Rettig RA. Editors introduction: why is revitalizing clinical research so important, yet so difcult? Perspect Biol Med 2004;47:47686. 60. Schenkein HA. Finding genetic risk factors for periodontal diseases: is the climb worth the view? Periodontol 2000 2002;30:7990. 61. Yoshie H, Kobayashi T, Tai H, Galicia JC. The role of genetic polymorphisms in periodontitis. Periodontol 2000 2007;43:10232. 62. Kornman KS. Mapping the pathogenesis of periodontitis: a new look. J Periodontol 2008;79:15608. 63. Nikolopoulos GK, Dimou NL, Hamodrakas SJ, Bagos PG. Cytokine gene polymorphisms in periodontal disease: a meta-analysis of 53 studies including 4178 cases and 4590 controls. J Clin Periodontol 2008;35:75467. 64. de Carvalho FM, Tinoco EMB, Govil M, Marazita ML, Vieira AR. Aggressive periodontitis is likely inuenced by a few small effect genes. J Clin Periodontol 2009;36:46873. 65. Huynh-Ba G, Lang NP, Tonetti MS, Salvi GE. The association of the composite IL-1 genotype with periodontitis progression and/or treatment outcomes: a systematic review. J Clin Periodontol 2007;34:30517. 66. Hodge P, Michalowicz B. Genetic predisposition to periodontitis in children and young adults. Periodontol 2000 2001;26:11334. 67. Reichert S, Machulla HKG, Klapproth J, Zimmermann U, Reichert Y, Gla ser C et al. Interferongamma and interleukin-12 gene polymorphisms and their relation to aggressive and chronic periodontitis and key periodontal pathogens. J Periodontol 2008;79:143443. Newton JT, Bower EJ. The social determinants of oral health: new approaches to conceptualizing and researching complex causal networks. Community Dent Oral Epidemiol 2005;33:2534. Cooper RS, Psaty BM. Genomics and medicine: distraction, incremental progress, or the dawn of a new age? Ann Intern Med 2003;138:57680. Lo e H, Theilade E, Jensen SB. Experimental gingivitis in man. J Periodontol 1965;36:17787. Lindhe J, Hamp S-E, Lo e H. Plaque induced periodontal disease in beagle dogs. A 4-year clinical, roentgenographical and histometrical study. J Periodont Res 1975;10:24355. Lindhe J, Ranney R, Lamster I, Charles A, Chung C-P, Flemmig T et al.1999 International Workshop for a Classication of Periodontal Diseases and Conditions. Papers. Oak Brook, Illinois, October 30 November 2, 1999. Consensus report: chronic periodontitis. Ann Periodontol 1999;4:38. Genco RJ, Van Dyke TE, Levine MJ, Nelson RD, Wilson ME. 1985 Kreshover lecture. Molecular factors inuencing neutrophil defects in periodontal disease. J Dent Res 1986;65:137991. Grossi SG. Treatment of periodontal disease and control of diabetes: an assessment of the evidence and need for future research. Ann Periodontol 2001;6:13845. Kikkert R, Laine ML, Aarden LA, Van Winkelhoff AJ. Activation of toll-like receptors 2 and 4 by gram-negative periodontal bacteria. Oral Microbiol Immunol 2007;22:14551. Yalda B, Offenbacher S, Collins JG. Diabetes as a modier of periodontal disease expression. Periodontol 2000 1994;6:3749. Kinane DF. Periodontitis modied by systemic factors. Ann Periodontol 1999;4:5463. Rothman KJ. Causes. Am J Epidemiol 1976;104:587 92. Merchant AT, Pitiphat W. Researching periodontitis: challenges and opportunities. J Clin Periodontol 2007;34:100715. Hart TC, Marazita ML, Wright JT. The impact of molecular genetics on oral health paradigms. Crit Rev Oral Biol Med 2000;11:2656. Rose G. Sick individuals and sick populations. Int J Epidemiol 1985;14:328. Marsh PD. Are dental diseases examples of ecological catastrophes? Microbiology 2003;149:27994. Kraemer HC, Stice E, Kazdin A, Offord D, Kupfer D. How do risk factors work together? Mediators, moderators, and independent, overlapping, and proxy risk factors. Am J Psychiatry 2001;158:848 56. Hujoel PP, Bergstro m J, del Aguila MA, DeRouen TA. A hidden periodontitis epidemic during the 20th century? Community Dent Oral Epidemiol 2003;31:16. Scadding JG. The concept of disease: a response. Psychol Med 1980;10:4257. lafsson O PA. Schleisner: a pioneer in epidemiolO ogy. J Clin Epidemiol 1999;52:9057.
68.
72.
73.
74.
75.
84.
85. 86.
394
The rationale behind periodontal classications c Semmelweis and the etiology of 87. Raju TNK. Igna fetal and neonatal sepsis. J Perinatol 1999;19:30710. 88. Paneth N. Assessing the contributions of John Snow to epidemiology. 150 years after removal of the Broad Street pump handle. Epidemiology 2004;15:5146. 89. Krieger N. Proximal, distal, and the politics of causation: whats level got to do with it? Am J Public Health 2008;98:22130. 90. Watt RG. From victim blaming to upstream action: tackling the social determinants of oral health inequalities. Community Dent Oral Epidemiol 2007;35:111. 91. Pearce N. Traditional epidemiology, modern epidemiology, and public health. Am J Public Health 1996;86:67883. 92. Krieger N. Does racism harm health? Did child abuse exist before 1962? On explicit questions, critical science, and current controversies: an ecosocial perspective. Am J Public Health 2003;93:1949. 93. McIntyre N. The truth, the whole truth, and nothing but the truth? In: Rothman KJ, editor. Causal Inference. Chestnut Hill, MA: Epidemiology Resources Inc; 1988; 13947. 94. MacMahon B, Trichopoulos D. Concepts of cause. Epidemiology. Principles and methods, 2nd edn. Boston: Little, Brown and Company; 1996; 1929. 95. Olsen J. What characterises a useful concept of causation in epidemiology? J Epidemiol Community Health 2003;57:868. 96. Krieger N. Ladders, pyramids and champagne: the iconography of health inequities. J Epidemiol Community Health 2008;62:1098104. 97. MacMahon B, Pugh TF, Ipsen J. Epidemiologic concepts of cause. Epidemiologic methods. Boston: Little, Brown & Co; 1960; 1122. 98. Krieger N. Epidemiology and the web of causation: has anyone seen the spider? Soc Sci Med 1994;39:887903. 99. Krieger N. Embodiment: a conceptual glossary for epidemiology. J Epidemiol Community Health 2005;59:3505. 100. Krieger N. The ostrich, the albatross, and public health: an ecosocial perspective or why an explicit focus on health consequences of discrimination and deprivation is vital for good science and public health practice. Public Health Rep 2001;116:419 23. 101. Kaufman JS, Cooper RS, McGee DL. Socioeconomic status and health in blacks and whites: the problem of residual confounding and the resiliency of race. Epidemiology 1997;8:6218. 102. Pearce N. Epidemiology as a population science. Int J Epidemiol 1999;28:S10158. 103. Wulff HR. What is understood by a disease entity? J R Coll Physicians Lond 1979;13:21920. 104. Bader JD, Shugars DA. What do we know about how dentists make caries-related treatment decisions? Community Dent Oral Epidemiol 1997;25:97 103. 105. Schacher B, Baron F, Ludwig B, Valesky E, Noack B, Eickholz P. Periodontal therapy in siblings with PapillonLefevre syndrome and tinea capitis: a report of two cases. J Clin Periodontol 2006;33:829 36. 106. Krill DB, Fry HR. Treatment of localized juvenile periodontitis (periodontosis). A review. J Periodontol 1987;58:18. 107. Scadding JG. Essentialism and nominalism in medicine: logic of diagnosis in disease terminology. Lancet 1996;348:5946.
395
This document is a scanned copy of a printed document. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material.